High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

被引：17

作者：

Silveira, Marina G. ^{[1
]}

Lindor, Keith D. ^{[1
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

来源：

JOURNAL OF HEPATOLOGY | 2008年 / 48卷 / 05期

关键词：

D O I：

10.1016/j.jhep.2008.02.002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：692 / 694

页数：3

相关论文

共 24 条

[1]

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial [J].

Angulo, P ;

Dickson, ER ;

Therneau, TM ;

Jorgensen, RA ;

Smith, C ;

DeSotel, CK ;

Lange, SM ;

Anderson, ML ;

Mahoney, DW ;

Lindor, KD .

JOURNAL OF HEPATOLOGY, 1999, 30 (05) :830-835

[2]

URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL [J].

BEUERS, U ;

SPENGLER, U ;

KRUIS, W ;

AYDEMIR, U ;

WIEBECKE, B ;

HELDWEIN, W ;

WEINZIERL, M ;

PAPE, GR ;

SAUERBRUCH, T ;

PAUMGARTNER, G .

HEPATOLOGY, 1992, 16 (03) :707-714

[3]

Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis [J].

Bjornsson, Einar ;

Angulo, Paul .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) :1677-1682

[4]

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis [J].

Boberg, KM ;

Rocca, G ;

Egeland, T ;

Bergquist, A ;

Broomé, U ;

Caballeria, L ;

Chapman, R ;

Hultcrantz, R ;

Mitchell, S ;

Pares, A ;

Rosina, F ;

Schrumpf, E .

HEPATOLOGY, 2002, 35 (03) :652-657

[5]

EFFECTS OF URSODEOXYCHOLIC ACID THERAPY FOR LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS [J].

COLOMBO, C ;

SETCHELL, KDR ;

PODDA, M ;

CROSIGNANI, A ;

RODA, A ;

CURCIO, L ;

RONCHI, M ;

GIUNTA, A .

JOURNAL OF PEDIATRICS, 1990, 117 (03) :482-489

[6]

URSODEOXYCHOLIC ACID THERAPY IN CYSTIC-FIBROSIS ASSOCIATED LIVER-DISEASE - A DOSE-RESPONSE STUDY [J].

COLOMBO, C ;

CROSIGNANI, A ;

ASSAISSO, M ;

BATTEZZATI, PM ;

PODDA, M ;

GIUNTA, A ;

ZIMMERNECHEMIAS, L ;

SETCHELL, KDR .

HEPATOLOGY, 1992, 16 (04) :924-930

[7]

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective [J].

Cullen, Susan N. ;

Rust, Christian ;

Fleming, Kenneth ;

Edwards, Cathryn ;

Beuers, Ulrich ;

Chapman, Roger W. .

JOURNAL OF HEPATOLOGY, 2008, 48 (05) :792-800

[8]

DeMaria N, 1996, HEPATO-GASTROENTEROL, V43, P1472

[9]

PRIMARY SCLEROSING CHOLANGITIS - REFINEMENT AND VALIDATION OF SURVIVAL MODELS [J].

DICKSON, ER ;

MURTAUGH, PA ;

WIESNER, RH ;

GRAMBSCH, PM ;

FLEMING, TR ;

LUDWIG, J ;

LARUSSO, NF ;

MALINCHOC, M ;

CHAPMAN, RW ;

KAPLAN, MM ;

MADDREY, WC ;

WILLIAMS, R ;

FARRANT, M ;

LANGWORTHY, A .

GASTROENTEROLOGY, 1992, 103 (06) :1893-1901

[10]

Harnois DM, 2001, AM J GASTROENTEROL, V96, P1558